Indications For Use; Contraindications; Basic Concept Training; Safety Guidelines And Operational Safety - CAIRE Eclipse 5 Provider Technical Maunal

Personal ambulatory oxygen system
Hide thumbs Also See for Eclipse 5:
Table of Contents

Advertisement

INDICATIONS FOR uSE

The Eclipse 5 is indicated for the administration of supplemental oxygen. The device is not intended for life support nor does
it provide any patient monitoring capabilities.
A physician must prescribe a specific oxygen flow rate setting to meet patients' individual needs.
Recommended oxygen flow rates should be adjusted only under the advice of a physician.
WARNING:

CONTRAINDICATIONS

WARNING:
WARNING:
WARNING:
WARNING:

BASIC CONCEPT TRAINING

The following section is intended to assist the provider to train the patient or caregiver to use the Eclipse 5. Topics in this
section should be discussed with each patient prior to release for use of the Eclipse 5.

SAFETy GuIDELINES AND OPERATIONAL SAFETy

WARNINGS & CAuTIONS
Provider should review all safety guidelines and operational safety Warnings/Cautions with each patient. In addition, provider
should carry out a risk assessment prior to installation of the Eclipse 5 to assure proper connection and compatibility with other
equipment the patient may be using.
Personal Ambulatory Oxygen System Provider Technical Manual
Federal law restricts this device to sell by or on the order
of a physician.
The Eclipse 5 is not intended for life supporting or life sustaining
applications, nor does it provide any patient monitoring capabilities.
In certain circumstances, the use of non-prescribed oxygen can be
hazardous. This device should only be used when prescribed by a
physician.
Not for use in the presence of flammable anesthetics.
As with any electrically powered device, the user may experience
periods of non-operation as a result of electrical power interruption,
or the need to have the Eclipse 5 serviced by a qualified technician.
The Eclipse 5 is not appropriate for any patient who would experience
adverse health consequences as a result of such temporary
interruption.
26
PN 20631679 Rev D

Hide quick links:

Advertisement

Table of Contents
loading

Table of Contents